PCR; minisatellite regions; allogeneic bone marrow transplantation It still remains unclear whether patients with mixed hematopoietic chimerism (MC) after allogeneic bone marrow transplantation (allo-BMT) have an increased
4,9,10
The conflicting up. One patient of 12 who had severe combined results in the literature might be explained on the basis of immunodeficiency (SCID), attained engraftment with a the experience that relapses from acute leukemias generally stable MC pattern. Three patients of 34 with CC develop within a shorter time period in comparison to cases relapsed lacking a transitional MC interval. However, with chronic leukemias. Therefore, studies with relatively the time span between last CC confirmation and relapse long intervals in patient follow-up may have missed the in each of these three patients was 6 months or longer.
critical and transient stage of MC. The hypothesis of a critiWe suggest that these patients also developed a stage of cal and transient stage of mixed chimerism was tested transitional MC but that the critical timepoint of molwithin a prospective study of patients after allo-BMT from ecular confirmation by PCR was missed as time intera single institution. Sequential analysis of the individual vals in the individual follow-up of these three patients chimerism status was performed within sufficiently shortwere too long (у у у6 months). In summary, the results time intervals. The results of this study demonstrate that demonstrate that the individual risk of developing the individual risk of relapse or graft failure is significantly relapse or graft failure is significantly enhanced in the enhanced in the MC situation. MC situation (P Ͻ Ͻ Ͻ 0.0005). Therefore the quantitative analysis of MC at short time intervals might be of great value to identify high risk patients which will have a significantly enhanced risk for relapse or graft rejection.rized in Table 1 (malignant diseases) and Table 2 Patients with malignant diseases (nonmalignant diseases). Each patient received unmanipulThe CC status was detected initially in 22 cases within the ated bone marrow either from HLA-identical (30/50) or group of 32 patients with malignant diseases after allofrom HLA-identical unrelated donors (13/50) Figure 2 . Concerning the indiof the seven primer pairs to obtain at least one informative vidual dynamics of MC the patients given in Figure 2 locus. Standardized mixed chimeric samples were genershowed particular characteristics. Patients who initially ated by mixing pretransplant recipient and donor DNA in exhibited MC and subsequently showed increasing amounts a range of percentages for each individual case. PCR analyof autologous DNA generally relapsed or rejected the graft. sis for the informative locus was carried out on sequential
In addition, two patients (UPN 22 with MDS and UPN 20 patient samples using the informative primer pair. PCR prowith AML) who developed MC beyond day +100 for the ducts were separated by polyacrylamide gel electrofirst time relapsed as well. Just two patients were exempt phoresis. After staining with ethidium bromide, signals from this general trend, (1) patient UPN 18 who suffered were analyzed densitometrically and results were taken on from AML rejected his graft 11 months post-transplant and the basis of individual standard curves. The sensitivity level continued to remain in complete remission for 2 years after to detect recipient between host DNA was generally in the BMT at the end of this study; (2) patient UPN 23 with range of 0.8%. Post-transplant DNA samples were investi-MDS showed increasing amounts of autologous marrow gated in sequences and the signal intensities were compared repopulation after the first transplant and subsequently to the standard curves.
relapsed on day +80 post-transplant. He received a second bone marrow transplantation 1 year later. Again, he developed MC with increasing autologous patterns postStatistics transplant. On day +40 when dysplastic cells were observed Statistical analysis was performed using Fisher's exact test.
in the peripheral blood, we discontinued the cyclosporin A A P value of P Ͻ 0.05 was considered significant.
prophylaxis and administered donor lymphocytes on day +45 post-transplant. The patient returned to CC on day +60 and dysplastic cells were no longer detectable in bone marEvaluation of the patients row or peripheral blood. The patient remained in complete continuous remission 6 months after the second transplant. Following engraftment peripheral blood samples were
In addition, one of eight patients with MC turned subinvestigated weekly when the leukocyte count exceeded sequently to CC and remained in complete continuous 500/l. After discharge of the patients, the majority of the remission (UPN 08 with ALL) 24 months from BMT. We samples were collected and analyzed monthly within an therefore suppose that patients with MC and decreasing observation period of 18 months after allo-BMT, with the autologous patterns might represent a group with a favorexception of a very few patients who could not be investiable prognosis. gated within the short intervals defined by our study design Although the numbers of patients with malignant dis-(see below). The follow-up of the patients from 1 January eases and MC in this study are still relatively small (n = 8), 1994 until 1 July 1996 ranged from 2 to 32 months (median statistical analysis showed a significant correlation 14.4 months). If an MC was detectable, we intensified the (P = 0.0079) between the finding of increasing autologous monitoring regimen by analyzing patient samples twice a signals and hematological relapse. week during the first 100 days post-transplant.
Patients with nonmalignant disease Results
We investigated follow-ups of 18 patients with nonmalignant diseases after allo-BMT. The CC status was initially We investigated the individual dynamics of chimerism in 50 follow-ups after allo-BMT from 46 pediatric patients detectable in 12/18 cases, 4/18 patients showed MC, and two patients recovered with their autologous marrow. The with malignant (n = 32) or nonmalignant (n = 18) diseases. Four patients received allo-BMT more than once. We found clinical course of the patients with nonmalignant diseases and MC is shown in Figure 3 . Two of four patients CC in 34/50 cases, 12/50 patients with initial CC developed MC, and 4/50 patients showed AC within the observation developed increasing autologous patterns within the observation period (1) patient UPN 30 with severe aplastic aneperiod. ADR = adrenoleukodystrophy; AR = autologous recovery; ATG = antithymocyte globulin; BU = busulfan; CML = chronic myelogenous leukemia; CC complete chimerism; CsA = cyclosporin A; CYC = cyclophosphamide; DFS = disease-free survival; ETO =etoposide; HIS =histiocytosis; MC = mixed chimerism; MTX =methotrexate; SAA = severe aplastic anemia; SCD = sickle cell disease; SCID = severe combined immunodeficiency; THA = thalassemia major; TNI total node irradiation; UPN = unique patient number; WAS = Wiskott-Aldrich syndrome. a Patient received two bone marrow transplants. This patient is alive without major clinical problems with a 12 month observation period post-transplant. Although statistical analysis showed a significant correlation between status but the underlying disease progressed, possible due to too long a delay until BMT could be performed. MC and graft rejection (P = 0.0286) in this group, the total number of study patients in this group is too small to draw final conclusions.
Correlation of graft-versus-host disease (GVHD) and Two patients (two of 18, UPN 43 and UPN 44) who chimerism status showed autologous recovery, suffered from histiocytosis and died shortly after transplantation secondary to the GVHD grades II-IV was only seen in one of 12 patients with MC (8.3%), but in 15/34 patients with CC (44.1%). underlying disease.
Another two patients (two of 18, UPN 41 and UPN 42, Statistical analysis revealed a significant correlation between the mixed chimerism status and GVHD grading of with adrenoleukodystrophy (ADR)) achieved a stable CC In contrast, just a minority of patients relapsed directly from the CC status without the finding of prior MC (3/34). However, in each of these cases the interval between last CC confirmation and relapse was more than 6 months. We therefore postulate that these patients may also have developed a stage of transitional MC but that the critical timing of molecular confirmation by PCR was missed. In contrast, each case in our study with subsequent relapse that could be followed at short time intervals was preceded The molecular finding of increasing autologous patterns seems to be a reflection of decreasing amounts of donor GVL effector cells. The importance of the immunological less than grade II (P = 0.035). No patient with autologous response after allo-BMT might be substantiated by our recovery showed any evidence of GVHD. The correlation finding that no patient with MC developed severe acute or between state of chimerism and GVHD grading is given in chronic GVHD which is considered to be associated with Table 3 .
the GVL effect. 25, 26 Therefore deficient immunological effector mechanisms may be responsible for the recurrence of pathological cells. One major implication is the identifiDiscussion cation of the critical time point for intervention, eg reduction of the immunosuppressive regimen or initiation Although several studies have been performed focusing on of donor lymphocyte support. Based on the above findings, the prognostic value of MC after allo-BMT, this issue is the critical time point is very reasonably given within the still controversial.
4,9,10,20, 21 The introduction of highly sensi-MC situation with increasing autologous patterns. Howtive methods for the identification of post-transplant ever, the choice of the ideal time point, the prognostic value engraftment and chimerism, like the fluorescence in situ of minimal residual disease, and the nature of adequate hybridization (FISH) or PCR technique, allowed detection regimens for intervention need to be addressed in future of the MC status more frequently in comparison to other studies. analytical methods, eg based on cytogenetic or restriction fragment length polymorphism (RFLP). However, a significant correlation between MC and relapse or graft rejecAcknowledgements tion could not be clearly demonstrated in these previous studies.
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